Skip to content
★ Sign in to follow
KJ

Karen J. Wilson

Executive
LAVA Therapeutics NVJazz Pharmaceuticals plcElicio Therapeutics, Inc.PDL Biopharma, Inc.
Total declarations
73
Companies
4
▲ Purchases (0 ops.)
—
▼ Sales (23 ops.)
€9.5M

Latest filing published 17 Nov 2025 for LAVA Therapeutics NV.

Filing timeline

BuySale
Karen J. Wilson

Insider track record

Disclosed buys
0
Disclosed sells
23
Signal history

Karen J. Wilson: trading record in brief

Karen J. Wilson has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Jazz Pharmaceuticals plc, Elicio Therapeutics, Inc. and LAVA Therapeutics NV. The record holds 73 filings, for trades running from 7 May 2009 to 13 November 2025.

Sales make up the whole of the open-market record (23 sales, €9.5M). The rest of the record consists of 30 share grants and 16 option exercises.

The record was last updated on 17 November 2025 with a transaction in LAVA Therapeutics NV. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Karen J. Wilson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations73 total

25 of 73 declarations